We are live on ! Find out more
SCLN

Sciclone Pharmaceuticals Inc
SCLN

Delisted

SCLN was delisted on the 13th of October, 2017.

Back to rankings

116 hedge funds and large institutions have $213M invested in Sciclone Pharmaceuticals Inc in 2014 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 40 increasing their positions, 34 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 7

52% more capital invested

Capital invested by funds: $141M → $213M (+$72.9M)

22% more funds holding

Funds holding: 95 → 116 (+21)

18% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 34

21% less call options, than puts

Call options by funds: $615K | Put options by funds: $778K

Holders
116
Holders Change
+21
Holders Change %
+22.11%
% of All Funds
3.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
28
Increased
40
Reduced
34
Closed
7
Calls
$615K
Puts
$778K
Net Calls
-$163K
Net Calls Change
-$409K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$4.56M
2
OAM
Oxford Asset Management
United Kingdom
+$4.26M
3
Morgan Stanley
Morgan Stanley
New York
+$1.82M
4
CAM
ClariVest Asset Management
California
+$1.72M
5
MC
Menta Capital
California
+$1.67M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$2.44M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.41M
3
LSV Asset Management
LSV Asset Management
Illinois
-$875K
4
Bank of America
Bank of America
North Carolina
-$725K
5
BIT
BlackRock Institutional Trust
California
-$723K
Name Holding Trade Value Shares
Change 		Change in
Stake
VKH
101
Virtu KCG Holdings
New York
$80K +$69.5K +11,595 New
Los Angeles Capital Management
102
Los Angeles Capital Management
California
$77K -$5.63K -940 -8%
Legal & General Group
103
Legal & General Group
United Kingdom
$67K +$58.2K +9,715 New
PCM
104
Prelude Capital Management
New York
$61K +$17.5K +2,916 +49%
SGAM
105
Smith Group Asset Management
Texas
$50K +$24.6K +4,100 +130%
Barclays
106
Barclays
United Kingdom
$45K -$147K -24,495 -76%
RA
107
Royce & Associates
New York
$34K -$60.5K -10,100 -67%
Citigroup
108
Citigroup
New York
$29K -$1.13K -189 -4%
BNP Paribas Financial Markets
109
BNP Paribas Financial Markets
France
$19.9K +$16.8K +2,811 +3,428%
BlackRock
110
BlackRock
New York
$16K – – –
Royal Bank of Canada
111
Royal Bank of Canada
Ontario, Canada
$14K -$8.99K -1,500 -43%
Teacher Retirement System of Texas
112
Teacher Retirement System of Texas
Texas
$12K -$288 -48 -3%
Ameriprise
113
Ameriprise
Minnesota
$7K +$887 +148 +20%
Creative Planning
114
Creative Planning
Kansas
$5K +$4.2K +700 New
GC
115
Globeflex Capital
California
$3K +$803 +134 +50%
Manulife (Manufacturers Life Insurance)
116
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$227 -$16.1K -2,687 -8%
GS
117
Gagnon Securities
New York
– -$336K -63,905 Closed
PP
118
Paloma Partners
Connecticut
– -$88K -16,719 Closed
ARTA
119
A.R.T. Advisors
New York
– -$84K -16,098 Closed
CCMH
120
Cornerstone Capital Management Holdings
New York
– -$69K -13,300 Closed
Prudential Financial
121
Prudential Financial
New Jersey
– -$61K -11,532 Closed
VFA
122
Virtus Fund Advisers
Connecticut
– -$23K -4,395 Closed
Bank of Montreal
123
Bank of Montreal
Ontario, Canada
– -$7K -1,360 Closed
1 2 3 4
5

SCLN Hedge Fund Activity: Q3 2014 in Review

116 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Sciclone Pharmaceuticals Inc (SCLN) for Q3 2014, worth a combined $213M — up 52% from $141M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SCLN positions and 7 closed out — a net gain of 21 holders — while 40 added to existing stakes and 34 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $4.56M. The largest seller was Franklin Resources, cutting an estimated $2.44M.

  • 116 institutional investors held Sciclone Pharmaceuticals Inc (SCLN) as of Q3 2014, up from 95 in Q2 2014.
  • Funds reported $213M of Sciclone Pharmaceuticals Inc stock for Q3 2014, up 52% quarter-over-quarter.
  • 28 funds opened new Sciclone Pharmaceuticals Inc positions in Q3 2014 and 7 closed out, a net change of +21 holders.
  • The largest Sciclone Pharmaceuticals Inc buyer in Q3 2014 was Acadian Asset Management, an estimated $4.56M added.
  • The largest Sciclone Pharmaceuticals Inc seller in Q3 2014 was Franklin Resources, an estimated $2.44M sold.

Based on aggregated 13F filings for Q3 2014.